Iovance Biotherapeutics Inc (IOVA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

999 SKYWAY ROAD SAN CARLOS, CA 94070

Iovance Biotherapeutics, Inc. operates as a biotechnology company. The Company focuses on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes for treatment of patients with cancer. Iovance Biotherapeutics serves customers in the United States.

Data based on most recent fiscal year report
Market Cap1.053 Billion Shares Outstanding72.63 Million Avg Volume848.487 Thousand
1-Yr BETA vs S&P TR Current Ratio15.1 Quick Ratio15.1
View SEC Filings from IOVA instead.
Q2 2019 All Institutions Hedge Funds 1
To trade IOVA now:
Filers who had this stock in their top 10: 12 10 (1.03%)
13F Filers holding this stock: 161 29 (3.0%)
Aggregate 13F shares on 06/30/2019: 122.116 Million 56.327 Million
Aggregate 13F shares on 03/31/2019: 117.302 Million 62.47 Million
Percent change: 4.10% -9.83%
Funds creating new positions: 42 9
Funds Adding to an existing position: 53 3
Funds closing out their position: 30 13
Funds reducing their position: 40 12
1 hedge funds as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding IOVA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COUNTOURIOTIS ATHENA PRESIDENT & CEO

  • Officer
  • Director
22,000 2019-09-10 2

KESSLER PAUL L. EXECUTIVE CHAIRMAN

  • Officer
  • 10% Owner
50,964,372 2019-08-30 0

SCHIFFMAN GREGORY T

50,815 2019-08-27 0

CATALDO TONY CEO

  • Officer
  • Director
  • 10% Owner
10,734,320 2019-08-14 0

VENKATESAN JAY

  • Director
650,049 2019-08-02 0

GRAF FINCKENSTEIN FRIEDRICH CHIEF MEDICAL OFFICER

  • Officer
0 2019-07-18 2

MCKILLIGAN RICHARD CHIEF FINANCIAL OFFICER

  • Officer
0 2019-06-27 0

MCPEAK MERRILL A

  • Director
0 2019-06-10 2

MAYNARD RYAN D

  • Director
0 2019-06-10 1

DUKES IAIN D.

  • Director
0 2019-06-10 2

WEISER MICHAEL

  • Director
0 2019-06-10 1

HENDERSON MOLLY EXECUTIVE VICE PRESIDENT & CFO

  • Officer
5,833 2019-04-11 0

FARDIS MARIA PRESIDENT AND CEO

  • Officer
  • Director
0 2019-03-04 1

MORRIS TIMOTHY E CHIEF FINANCIAL OFFICER

  • Officer
0 2019-03-04 1

VOGT FREDERICK G GENERAL COUNSEL

  • Officer
0 2019-03-04 1

ROTHBAUM WAYNE P.

  • Director
7,067,333 2018-12-04 1

HILLSBERG SANFORD

  • Director
56,950 2017-10-10 0

AHN MARK J

  • Director
0 2016-12-13 0

VALLE FRANCO PRINCIPAL ACCOUNTING OFFICER

  • Officer
130 2016-08-22 0

BROOKE ROBERT T. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2016-07-15 0

BRISTOL INVESTMENT FUND LTD

  • 10% Owner
463,806 2016-04-04 0

LOTZE MICHAEL CHIEF SCIENTIFIC OFFICER

  • Officer
0 2016-03-28 0

BENDER JAMES G. VICE PRESIDENT - MANUFACTURING

  • Officer
0 2016-03-11 0

HAWKINS ELMA PRESIDENT & CEO

  • Officer
  • Director
0 2016-03-11 0

FISCHKOFF STEVEN A. CHIEF MEDICAL OFFICER

  • Officer
0 2016-02-04 0

HANDELMAN MICHAEL D CHIEF FINANCIAL OFFICER

  • Officer
0 2016-02-03 0

AYER CAPITAL MANAGEMENT, LP

AYER CAPITAL PARTNERS, LLC

ACM CAPITAL PARTNERS, LLC

  • 10% Owner
No longer subject to file 2015-05-06 0

BRISTOL CAPITAL LLC

  • 10% Owner
444,000 2014-12-31 0

RADVANYI LASZLO CHIEF SCIENTIFIC OFFICER

  • Officer
0 2014-12-05 0

VOYTICKY DAVID J

  • FORMER PRESIDENT
No longer subject to file 2014-08-12 0

AYER CAPITAL MANAGEMENT, LP

AYER CAPITAL PARTNERS, LLC

ACM CAPITAL PARTNERS, LLC

VENKATESAN JAY

  • Director
  • 10% Owner
5,604,015 2013-12-31 0

SINGH MANISH PRESIDENT AND CEO

  • Officer
  • Director
  • 10% Owner
2,546,000 2013-12-30 0

AYER CAPITAL MANAGEMENT, LP

  • Director
  • 10% Owner
560,401,150 2013-05-22 0

SCHROEDER MARTIN

  • Director
1,000,000 2011-08-22 0

ANDREWS WILLIAM H

  • Director
0 2011-03-16 0

COLES L. STEPHEN

  • Director
0 2011-02-22 0

HAMILTON ATLANTIC

  • 10% Owner
0 2010-03-31 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments